Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system

por McDannold, Nathan, Zhang, Yongzhi, Supko, Jeffrey G., Power, Chanikarn, Sun, Tao, Vykhodtseva, Natalia, Golby, Alexandra J., Reardon, David A.
Publicado 2020

Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma mode...

por McDannold, Nathan, Zhang, Yongzhi, Supko, Jeffrey G., Power, Chanikarn, Sun, Tao, Peng, Chengueng, Vykhodtseva, Natalia, Golby, Alexandra J, Reardon, David A.
Publicado 2019

Oncolytic Herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation

por Yamada, Suguru, Kuroda, Toshihiko, Fuchs, Bryan C., He, Xiaoying, Supko, Jeffrey G., Schmitt, Anthony, McGinn, Christopher M., Lanuti, Michael, Tanabe, Kenneth K.
Publicado 2011

Chemical Genetics Identify eIF2α Kinase Heme Regulated Inhibitor as Anti-Cancer Target

por Chen, Ting, Ozel, Duygu, Qiao, Yuan, Harbinski, Fred, Chen, Limo, Denoyelle, Séverine, He, Xiaoying, Zvereva, Nela, Supko, Jeffrey G., Chorev, Michael, Halperin, Jose A., Aktas, Bertal H.
Publicado 2011

A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma

por Blum, Kristie A., Supko, Jeffrey G., Maris, Michael B., Flinn, Ian W., Goy, Andre, Younes, Anas, Bobba, Suresh, Senderowicz, Adrian M., Efuni, Sergey, Rippley, Ronda, Colak, Gozde, Trojer, Patrick, Abramson, Jeremy S.
Publicado 2022

Tumor suppression by small molecule inhibitors of translation initiation

por Chen, Limo, Aktas, Bertal H, Wang, Yibo, He, Xiaoying, Sahoo, Rupam, Zhang, Nancy, Denoyelle, Severine, Kabha, Eihab, Yang, Hongwei, Freedman, Revital Yefidoff, Supko, Jeffrey G, Chorev, Michael, Wagner, Gerhard, Halperin, Jose A
Publicado 2012

Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer

por Spring, Laura M., Clark, Shealagh L., Li, Tianyu, Goel, Shom, Tayob, Nabihah, Viscosi, Elene, Abraham, Elizabeth, Juric, Dejan, Isakoff, Steven J., Mayer, Erica, Moy, Beverly, Supko, Jeffrey G., Tolaney, Sara M., Bardia, Aditya
Publicado 2021

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

por Rosenfeld, Myrna R, Ye, Xiaobu, Supko, Jeffrey G, Desideri, Serena, Grossman, Stuart A, Brem, Steven, Mikkelson, Tom, Wang, Daniel, Chang, Yunyoung C, Hu, Janice, McAfee, Quentin, Fisher, Joy, Troxel, Andrea B, Piao, Shengfu, Heitjan, Daniel F, Tan, Kay-See, Pontiggia, Laura, O’Dwyer, Peter J, Davis, Lisa E, Amaravadi, Ravi K
Publicado 2014